Savillex, LLC, based in Eden Prairie, Minn., said it has completed its acquisition of Entegris, Inc.’s Life Sciences Fluid Management business. Entegris is based in Billerica, Mass. The acquired portfolio includes bioprocessing and pharmaceutical manufacturing solutions, including Aramus and PE bags, single-use assemblies and components used across discovery, clinical and commercial manufacturing.
Savillex said the acquisition expands its life sciences offerings with a broader portfolio of high-performance single-use solutions. The company also gains the Life Sciences Fluid Management team and its technologies in high-purity fluid management. According to Savillex, customers can expect expanded single-use solutions, additional technical expertise and enhanced capabilities supporting applications from early-stage research through commercial manufacturing.
Eric Giesing, chief executive officer of Savillex, said the Aramus product line fits alongside the company’s Savillex, Containment and Bioprocessing offerings. He said the acquisition expands the portfolio for biopharmaceutical and pharmaceutical customers and that Savillex will continue investing in technologies intended to help customers accelerate development and production of critical therapies.
Chris Bedi, general manager of Fluid Management at Savillex, said the acquired portfolio complements Savillex’s existing capabilities. He said the combined business will continue providing fluid management solutions while expanding support for partners across drug development.
Savillex said the transaction advances its strategy of providing solutions for the life sciences market and its commitment to innovation, quality and customer partnership. Terms of the transaction were not disclosed. EC M&A served as financial advisor and Sidley Austin LLP served as legal counsel to Savillex.